RxDoctor Payments Data

William Walker, MD

Family Medicine · Fairmont, WVNPI 1427390905

Payments from drug & device makers

$4,767in general payments, 2019–2025

Across 259 payments — averaging $18.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$569
  • Exact Sciences$380
  • AstraZeneca$372
  • Bayer$343
  • Astellas Pharma US Inc$334
  • plus $2K from 14 others

What the payments were for

  • Food & beverage$4,67798%
  • Education$902%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,767 in reported general payments places this provider in the 90th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$68,464
Medicare patients
142
Services billed
1,062

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin58$79,737
EliquisApixaban34$32,698
MounjaroTirzepatide19$27,999
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$27,163
OzempicSemaglutide23$26,883
TrulicityDulaglutide18$22,081
XareltoRivaroxaban15$18,522
RybelsusSemaglutide14$15,939
LinzessLinaclotide11$13,049
KerendiaFinerenone14$11,549
Incruse ElliptaUmeclidinium Bromide15$4,939
Novolog Mix 70-30Insulin Aspart Prot/Insuln Asp15$3,245
Metaxalone11$2,112
SynthroidLevothyroxine Sodium27$1,968
Atorvastatin Calcium204$1,746

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$232$79,73758 claims
Lilly USA, LLCMounjaro, Trulicity$292$50,08037 claims
Novo NordiskOzempic, Rybelsus, Novolog Mix 70-30$569$46,06752 claims
PfizerEliquis$327$32,69834 claims
GSKTrelegy Ellipta, Incruse Ellipta$89$32,10146 claims
AbbVieLinzess, Synthroid$1,113$15,01738 claims
BayerKerendia$343$11,54914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 843 family medicine providers in West Virginia.

Other family medicine in Fairmont

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →